Press Releases Pacira BioSciences, Inc.

Equities

PCRX

US6951271005

Real-time Estimate Cboe BZX Other stock markets 03:21:03 2024-04-29 pm EDT			5-day change	1st Jan Change
26.22 ^USD	-0.42%		+0.42%	-22.32%

Mar. 13	Transcript : Pacira BioSciences, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 01:35 PM
Mar. 13	Pacira BioSciences Says US FDA Granted Knee Osteoarthritis Therapy Candidate RMAT Designation	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference	Apr. 02	GL
Beyond the Pill: Athletes Champion PEMF and Non-Opioid Solutions for Pain Management (ENDV)	Mar. 20	AQ
Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee	Mar. 13	GL
Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee	Mar. 13	AQ
Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference	Mar. 06	GL
Pacira: Q4 Earnings Snapshot	Feb. 29	AQ
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results	Feb. 29	GL
Pacira to Report 2023 Financial Results on Thursday February 29, 2024	Feb. 22	GL
Pacira to Report 2023 Financial Results on Thursday February 29, 2024	Feb. 22	AQ
Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy	Feb. 15	GL
Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.	Feb. 07	GL
G.O.A.T. Bowl I Registration Open to 4 Additional Pickleball Teams	Feb. 01	PR
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues	Jan. 04	GL
Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 03	GL
Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 03	AQ
Pacira Appoints Frank D. Lee as Chief Executive Officer	Dec. 21	GL
Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications	Nov. 10	GL
Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November	Nov. 07	GL
Pacira: Q3 Earnings Snapshot	Nov. 02	AQ
Pacira BioSciences Reports Third Quarter 2023 Financial Results	Nov. 02	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Pacira BioSciences, Inc.

Equities

PCRX

US6951271005

Press Releases

Filters